Biomarkers of COVID-19 severity may not serve patients with polycystic ovary syndrome

Journal of Translational Medicine

Thozhukat Sathyapalan¹  Abu Saleh Md Moin²  Manjula Nandakumar²  Alexandra E. Butler²  Stephen L. Atkin³ 

[1] Academic Endocrinology, Diabetes and Metabolism, Hull York Medical School, Hull, UK;Diabetes Research Center (DRC), Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), PO Box 34110, Doha, Qatar;Royal College of Surgeons in Ireland Bahrain, Adliya, Kingdom of Bahrain;

关键词: Biomarkers;    Polycystic ovary syndrome;    COVID-19;    SARS-CoV-2;    Platelet degranulation;    Coagulation factors;   

DOI  :  10.1186/s12967-021-02723-7

来源: Springer

【 授权许可】

CC BY